Aurobindo Pharma Received an Approval from USFDA for Generic Cefadroxil Oral Suspension

Aurobindo Pharma on 26 April 2013 announced that it received an approval from USFDA for generic Cefadroxil oral suspension.

Created On: Apr 26, 2013 15:58 ISTModified On: Apr 26, 2013 16:02 IST

Aurobindo Pharma, the drug firm on 26 April 2013 announced that it received an approval from US Food & Drug Administration (USFDA), the US health regulator for manufacturing as well as marketing the generic Cefadroxil oral suspension. Generic Cefadroxil is used for the treatment of bacterial infections in US market.

Aurobindo Pharma got an approval from US Food & Drug Administration (USFDA) for manufacturing and marketing Cefadroxil in strengths of 250mg/5mL and 500mg/5mL. Cefadroxil is generic equivalent of Duricef of Warner Chilcott Company Inc. Duricef is also used for oral suspension in similar strength.

Cefadroxil oral suspension got approval out of cephalosporin formulations manufacturing facility of the company in Hyderabad.

With this, Aurobindo Pharma got a total of 187 abbreviated new drug application (ANDA) approvals from the US health regulator. This includes 4 from Aurolife Pharma LLC and 27 tentative approvals.


US Food and Drug Administration Lifted Import Alert on Aurobindo Pharma

Aurobindo Pharm received Approval from USFDA to Manufacture & Market Divalproex

Aurobindo Received Approval for Ondansetron

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

Comment ()

Post Comment

3 + 3 =